Chemical formula: C₉H₁₈N₆  Molecular mass: 210.279 g/mol  PubChem compound: 2123

Active ingredient description

Altretamine is an antineoplastic agent. It is indicated for use as a single agent in the palliative treatment of patients with persistent or recurrent ovarian cancer following first-line therapy with cisplatin and/or alkylating agent-based combination. It is not considered a first-line treatment, but it can be useful as salvage therapy.

Medicine classification

This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:

ATC code Group title Classification
L01XX03 Altretamine L Antineoplastic and immunomodulating agents → L01 Antineoplastic agents → L01X Other antineoplastic agents → L01XX Other antineoplastic agents
Discover more medicines within L01XX03

Structural formula

Graphic representation of the active ingredient's molecular structure

External identifiers

CAS Substance: 645-05-6
DrugBank Drug: DB00488
PubChem Compound: 2123
RxNorm Ingredient: 5296
SNOMED-CT Concept: 387385000
Altretamine (substance)
UNII Identifier: Q8BIH59O7H


Altretamine is an active ingredient of these brands:

France (FR)

Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.